A detailed history of James J. Burns & Company, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, James J. Burns & Company, LLC holds 100,111 shares of WVE stock, worth $1.35 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
100,111
Previous 90,000 11.23%
Holding current value
$1.35 Million
Previous $449,000 82.85%
% of portfolio
0.15%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$5.12 - $9.01 $51,768 - $91,100
10,111 Added 11.23%
100,111 $821,000
Q2 2024

Jul 17, 2024

BUY
$4.38 - $6.48 $394,200 - $583,200
90,000 New
90,000 $449,000
Q4 2023

Feb 13, 2024

BUY
$4.16 - $6.87 $133,120 - $219,840
32,000 Added 96.83%
65,049 $328,000
Q3 2023

Nov 07, 2023

BUY
$3.56 - $5.75 $10,854 - $17,531
3,049 Added 10.16%
33,049 $190,000
Q2 2023

Jul 27, 2023

BUY
$3.51 - $4.69 $105,300 - $140,700
30,000 New
30,000 $109,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track James J. Burns & Company, LLC Portfolio

Follow James J. Burns & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James J. Burns & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on James J. Burns & Company, LLC with notifications on news.